Development of a metric to detect and decrease low-value prescribing in older adults.

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults – JAMA Network Open

Invited Commentary: Considering Value in Prescribing and Deprescribing for Older Adults – JAMA

Commentary on Twitter

In this qualitative study, a scientifically valid and clinically useful low-value prescribing metric was built. EVOLV-Rx may enhance the detection of low-value prescribing practices, reduce polypharmacy, and enable older adults to receive high-value care. https://t.co/GtrsUboT9o

— JAMA Network Open (@JAMANetworkOpen) February 15, 2022